Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Hammel

Showing results (201-210 of 241) with videos related to

Pageof 25
Sort By:
Cancer Medicine|January 26, 2016
PEPCOL: a GERCOR randomized phase II study of nanoliposomal irinotecan PEP02 (MM-398) or irinotecan with leucovorin/5-fluorouracil as second-line therapy in metastatic colorectal cancerBenoist Chibaudel, Frédérique Maindrault-Gœbel, Jean-Baptiste Bachet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 14, 2023
Prediction of Adjuvant Gemcitabine Sensitivity in Resectable Pancreatic Adenocarcinoma Using the GemPred RNA Signature: An Ancillary Study of the PRODIGE-24/CCTG PA6 Clinical TrialRémy Nicolle, Jean-Baptiste Bachet, Alexandre Harlé, et al.
Cancers|April 3, 2021
Pancreatic Ductal Adenocarcinoma Arising in Young and Old Patients Displays Similar Molecular FeaturesJérôme Raffenne, Fernando A Martin, Rémy Nicolle, et al.
British Journal of Cancer|March 7, 2019
Can we classify ampullary tumours better? Clinical, pathological and molecular features. Results of an AGEO studyGeraldine Perkins, Magali Svrcek, Cecile Bouchet-Doumenq, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 17, 2018
Pancreatic cancer: French clinical practice guidelines for diagnosis, treatment and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, AFC)Cindy Neuzillet, Sébastien Gaujoux, Nicolas Williet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 14, 2022
Overall Survival Results From the POLO Trial: A Phase III Study of Active Maintenance Olaparib Versus Placebo for Germline BRCA-Mutated Metastatic Pancreatic CancerHedy L Kindler, Pascal Hammel, Michele Reni, et al.
The New England Journal of Medicine|June 4, 2019
Maintenance Olaparib for Germline <i>BRCA</i>-Mutated Metastatic Pancreatic CancerTalia Golan, Pascal Hammel, Michele Reni, et al.
The New England Journal of Medicine|February 11, 2011
Sunitinib malate for the treatment of pancreatic neuroendocrine tumorsEric Raymond, Laetitia Dahan, Jean-Luc Raoul, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 4, 2025
Neoadjuvant FOLF(IRIN)OX Chemotherapy for Resectable Pancreatic Adenocarcinoma: A Multicenter Randomized Noncomparative Phase II Trial (PANACHE01 FRENCH08 PRODIGE48 study)Lilian Schwarz, Jean-Baptiste Bachet, Aurelia Meurisse, et al.
Therapeutic Advances in Medical Oncology|October 6, 2025
Management of biliary tract cancers in elderly patients: a French multicenter retrospective study (PRONOBIL-ACABi)Marine Valery, Julien Edeline, Julie Henriques, et al.
Pageof 25

Showing results (201-210 of 241) with videos related to

Sort By:
Pageof 25
Cancer Medicine|January 26, 2016
PEPCOL: a GERCOR randomized phase II study of nanoliposomal irinotecan PEP02 (MM-398) or irinotecan with leucovorin/5-fluorouracil as second-line therapy in metastatic colorectal cancerBenoist Chibaudel, Frédérique Maindrault-Gœbel, Jean-Baptiste Bachet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 14, 2023
Prediction of Adjuvant Gemcitabine Sensitivity in Resectable Pancreatic Adenocarcinoma Using the GemPred RNA Signature: An Ancillary Study of the PRODIGE-24/CCTG PA6 Clinical TrialRémy Nicolle, Jean-Baptiste Bachet, Alexandre Harlé, et al.
Cancers|April 3, 2021
Pancreatic Ductal Adenocarcinoma Arising in Young and Old Patients Displays Similar Molecular FeaturesJérôme Raffenne, Fernando A Martin, Rémy Nicolle, et al.
British Journal of Cancer|March 7, 2019
Can we classify ampullary tumours better? Clinical, pathological and molecular features. Results of an AGEO studyGeraldine Perkins, Magali Svrcek, Cecile Bouchet-Doumenq, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 17, 2018
Pancreatic cancer: French clinical practice guidelines for diagnosis, treatment and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, AFC)Cindy Neuzillet, Sébastien Gaujoux, Nicolas Williet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 14, 2022
Overall Survival Results From the POLO Trial: A Phase III Study of Active Maintenance Olaparib Versus Placebo for Germline BRCA-Mutated Metastatic Pancreatic CancerHedy L Kindler, Pascal Hammel, Michele Reni, et al.
The New England Journal of Medicine|June 4, 2019
Maintenance Olaparib for Germline <i>BRCA</i>-Mutated Metastatic Pancreatic CancerTalia Golan, Pascal Hammel, Michele Reni, et al.
The New England Journal of Medicine|February 11, 2011
Sunitinib malate for the treatment of pancreatic neuroendocrine tumorsEric Raymond, Laetitia Dahan, Jean-Luc Raoul, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 4, 2025
Neoadjuvant FOLF(IRIN)OX Chemotherapy for Resectable Pancreatic Adenocarcinoma: A Multicenter Randomized Noncomparative Phase II Trial (PANACHE01 FRENCH08 PRODIGE48 study)Lilian Schwarz, Jean-Baptiste Bachet, Aurelia Meurisse, et al.
Therapeutic Advances in Medical Oncology|October 6, 2025
Management of biliary tract cancers in elderly patients: a French multicenter retrospective study (PRONOBIL-ACABi)Marine Valery, Julien Edeline, Julie Henriques, et al.
Pageof 25